Patents Represented by Attorney Isis Pharmaceuticals Patent Department Jones Day

Find this attorney in the Justia Lawyer Directory

  • Modulation of eIF4E-BP2 expression
    Patent number: 8067386
    Abstract: Compounds, compositions and methods are provided for modulating the expression of eIF4E-BP2. The compositions comprise oligonucleotides, targeted to nucleic acid encoding eIF4E-BP2. Methods of using these compounds for modulation of eIF4E-BP2 expression and for diagnosis and treatment of diseases and conditions associated with expression of eIF4E-BP2 are provided.
    Type: Grant
    Filed: November 19, 2008
    Date of Patent: November 29, 2011
    Assignee: Isis Pharmaceuticals, Inc.
    Inventors: Sanjay Bhanot, Kenneth W. Dobie, Ravi Jain